EGFR-Targeted Therapy in NSCLC: First Find the Targets, Then Treat With Precision

(21:41)

Upfront EGFR-Targeted Therapy for NSCLC

(4:41)

What targeted therapies are used for people with the EGFR mutation?

(1:56)

Understanding NSCLC Treatment When You Have an EGFR Mutation

(5:3)

Maximizing the Impact of EGFR-Targeted Therapy in Resectable NSCLC

(43:35)

Upfront EGFR-Targeted Therapy

(8:28)

Dr. Villaruz on EGFR-Targeted Therapies in NSCLC

(1:)

EGFR Mutations in Advanced NSCLC - Targeted Therapies in Lung Cancer 2023

(4:10)

Targeting EGFR-positive NSCLC with antibody-drug conjugates

(1:25)

Leveraging Immunotherapy and EGFR Targeted Treatment in Unresectable Stage III NSCLC

(55:59)

EGFR-Targeted Therapy for Squamous NCSLC

(8:27)

EGFR-Targeted Therapy in Metastatic Colorectal Cancer

(7:42)

Targeted treatment with EGFR TKIs: Front line options

(20:24)

Dermatologic Side Effects of EGFR-TKIs - 2022 Program: Targeted Therapies Forum

(10:4)

What is EGFR in Lung Cancer? - 2022 Program: Targeted Therapies Forum

(4:22)

2023 Best of Lung: Targeted Therapies in Lung Cancer

(30:32)

Anti-EGFR therapy for RAS wild-type left-sided colorectal cancer

(2:10)

A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLC

(32:15)

Dr. Lynch on Targeting EGFR Mutation Subtypes in Lung Cancer

(1:29)